Tabitha Moe in Phoenix, Arizona

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: University Of Missouri, Kansas City, School Of Medicine
Graduation Year: 2007
The Primary Medical Specialty for Tabitha Moe is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 17
PAC (PECOS ID)#: 6103950720
NPI #: 1508067588
NPI Created On: 05/29/2007
NPI Last Updated Listed as: 04/26/2018
Primary Taxonomy Code: 207RC0000X
License Number:
44311
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• Health Net of Arizona, Inc.
• Humana
• Oscar Health Plan, Inc.
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

1. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
2. Routine ekg using at least 12 leads including interpretation and report
3. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
4. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
5. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
6. Insertion of probe in esophagus for heart ultrasound examination including interpretation and report
7. Doppler ultrasound study of color-directed heart blood flow, rate, and valve function
8. Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes
9. New patient office or other outpatient visit, typically 45 minutes
10. New patient office or other outpatient visit, typically 60 minutes
11. Established patient office or other outpatient, visit typically 25 minutes
12. Established patient office or other outpatient, visit typically 40 minutes
13. Initial hospital inpatient care, typically 70 minutes per day
14. Subsequent hospital inpatient care, typically 25 minutes per day
15. Subsequent hospital inpatient care, typically 35 minutes per day
16. Technetium tc-99m sestamibi, diagnostic, per study dose
17. Injection, regadenoson, 0.1 mg